What ADMA Biologics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 5 |
| Sells | 0 | 9 |
| Total trades | 0 | 46 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 698,926 |
| Disposed | 0 | 433,437 |
| Net activity | +0 | +265,489 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Kestenberg-Messina Kaitlin M. | COO and SVP, Compliance | Jul 24 | Withheld — tax / exercise cost · F | −3,177 | $8.37 | −$26.6K | 443,061 |
| Kohler Terry | CFO and Treasurer | Jul 16 | Grant / award · A | +85,130 | — | — | 143,149 |
| Grossman Jerrold B | Director | May 27 | Open-market buy · P | +6,400 | $7.91 | +$50.6K | 520,284 |
| Grossman Jerrold B | Director | May 12 | Open-market buy · P | +12,500 | $8.01 | +$100K | 513,884 |
| Grossman Jerrold B | Director | May 11 | Open-market buy · P | +12,500 | $8.01 | +$100K | 501,384 |
| Kestenberg-Messina Kaitlin M. | COO and SVP, Compliance | Apr 01 | Withheld — tax / exercise cost · F | −20,362 | $9.11 | −$185K | 446,238 |
| Guiheen Lawrence P. | Director | Mar 17 | Gift · G | +30,000 | — | — | 30,000 |
| Guiheen Lawrence P. | Director | Mar 17 | Gift · G | −30,000 | — | — | 105,520 |
| Grossman Adam S | President and CEO | Mar 16 | Sale for tax withholding · S | −6,000 | $15.16 | −$91K | 2,112,777 |
| Grossman Adam S | President and CEO | Mar 16 | Disclosed 10b5-1 sale · S | −15,000 | $15.16 | −$227K | 2,118,777 |
| Grossman Adam S | President and CEO | Mar 16 | Exercise / conversion · M | +15,000 | $5.40 | +$81K | 2,133,777 |
| Guiheen Lawrence P. | Director | Mar 13 | Exercise / conversion · M | +30,000 | $3.66 | +$110K | 135,520 |
| Kestenberg-Messina Kaitlin M. | COO and SVP, Compliance | Mar 09 | Sale for tax withholding · S | −10,096 | $15.63 | −$158K | 466,600 |
| Kestenberg-Messina Kaitlin M. | COO and SVP, Compliance | Mar 09 | Exercise / conversion · M | +2,175 | $1.55 | +$3.37K | 476,696 |
| Kestenberg-Messina Kaitlin M. | COO and SVP, Compliance | Mar 09 | Exercise / conversion · M | +1,525 | $2.35 | +$3.58K | 474,521 |
| Kestenberg-Messina Kaitlin M. | COO and SVP, Compliance | Mar 09 | Exercise / conversion · M | +2,646 | $2.83 | +$7.49K | 472,996 |
| Kestenberg-Messina Kaitlin M. | COO and SVP, Compliance | Mar 09 | Exercise / conversion · M | +1,250 | $4.31 | +$5.39K | 470,350 |
| Kestenberg-Messina Kaitlin M. | COO and SVP, Compliance | Mar 09 | Exercise / conversion · M | +2,500 | $5.00 | +$12.5K | 469,100 |
| Kestenberg-Messina Kaitlin M. | COO and SVP, Compliance | Mar 09 | Other Transaction · J | −91,266 | — | — | 466,600 |
| Grossman Adam S | President and CEO | Mar 07 | Withheld — tax / exercise cost · F | −29,513 | $15.39 | −$454K | 2,118,777 |
Loading...
